Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors Versus Bevacizumab in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2015.572
Full Text
Open PDFAbstract
Available in full text
Date
May 15, 2015
Authors
Publisher
Spandidos Publications